Vical

Axe and chopping block

Biotech

Vical stops antifungal trial, lays off staff to eke out cash

The cost-cutting actions come as Vical tries to eke out its cash while looking into strategic alternatives.

Nick Paul Taylor Feb 20, 2019 9:24am

Compass in a mans hand

Vical ‘considering options’ after pipeline woes

Jul 19, 2018 10:02am

Microbiologist Scientist

More bad news for Vical as it abandons herpes vaccine

Jun 11, 2018 9:33am

Astellas

After years of setbacks, Vical to slash jobs, Astellas drug work

Jan 31, 2018 4:03am

Research

Another Vical vax flop, this time with Astellas-partnered CMV vaccine

Sep 19, 2016 7:16am